Tuesday 13 October 2026
Export SLSN’s income statement to Excel — free account
Solesence, Inc.
SLSN Consumer Defensive Household & Personal Products
Solesence, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.1 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 24.7%, EPS fell 105.5%, free cash flow grew 86.5% and total debt rose 36.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.02
0.00
0.00%
Follow SLSN
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
82.90 | 37.48 | 0.00 | 0.00 | 79.71 | 34.55 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
2 | 7 | 1 | 1 | 6 | 4 | 2 | 1 | 2 | 3 |
P/S ratio |
1.81 | 2.91 | 0.80 | 1.49 | 6.72 | 1.89 | 0.82 | 1.74 | 1.31 | 2.06 |
Altman Z-Score |
1.02 | 1.26 | (3.08) | (1.99) | 2.39 | (6.71) | (13.84) | (16.63) | (16.07) | (19.03) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 443.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(3.70) | (4.94) | (10.89) | (9.42) | (9.22) | (22.02) | (36.45) | (49.25) | (46.76) | (61.33) |
Beneish M-Score |
(1.13) | (2.07) | (3.16) | (2.49) | (0.88) | (0.36) | 37.53 | (3.35) | (1.23) | (3.76) |
P/Operating CF |
61.87 | 69.50 | (11.22) | 74.30 | 96.54 | (98.59) | (16.66) | (58.73) | (173.35) | 196.96 |
P/B ratio |
7.99 | 10.18 | 15.63 | 9.83 | 26.54 | 11.87 | 6.78 | 17.87 | 5.04 | 7.97 |
Price to Tangible BV |
7.99 | 10.18 | 15.63 | 9.83 | 26.54 | 11.87 | 6.78 | 17.87 | 5.04 | 7.97 |
EV/Sales |
2.04 | 3.09 | 1.04 | 1.65 | 6.77 | 1.99 | 0.85 | 1.73 | 1.20 | 1.93 |
EV/EBITDA |
51.25 | 26.72 | 0.00 | 0.00 | 50.93 | 16.18 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(14.77) | 82.15 | (19.35) | (37.33) | 85.93 | (16.56) | (3.84) | (18.32) | (15.58) | (86.26) |
EV/FCF |
(11.81) | (62.59) | (12.70) | (13.77) | 446.18 | (11.62) | (3.03) | (16.37) | (14.49) | (51.20) |
Quick Ratio |
0.58 | 0.24 | 0.33 | 0.50 | 0.63 | 0.57 | 0.49 | 0.60 | 1.52 | 1.71 |
Current Ratio |
2.07 | 1.14 | 1.05 | 1.20 | 1.58 | 1.30 | 1.13 | 1.29 | 2.28 | 2.64 |
Net Debt/EBITDA |
5.66 | 0.59 | (3.24) | (3.60) | 0.09 | 0.81 | (0.17) | 0.20 | 3.60 | 2.54 |
Debt/Assets |
30.50% | 10.00% | 32.88% | 24.68% | 3.54% | 19.64% | 17.26% | 15.31% | 6.64% | 2.27% |
Debt/Equity |
0.87 | 0.33 | 5.68 | 1.47 | 0.13 | 0.97 | 1.07 | 0.73 | 0.13 | 0.04 |
Asset Turnover |
1.24 | 1.26 | 1.12 | 1.20 | 1.41 | 1.49 | 1.57 | 2.21 | 2.25 | 2.29 |
Operating CF/Net income |
(4.79) | 0.47 | 0.46 | 0.63 | 1.00 | (2.08) | 0.92 | 0.64 | 1.22 | 0.19 |
Capex/Depreciation |
(2.39) | (4.91) | (1.42) | (4.98) | (1.38) | (1.40) | (2.14) | (0.50) | (0.21) | (0.27) |
Interest Coverage |
1.69 | 7.66 | (4.23) | (5.91) | 2.22 | 2.99 | (13.31) | (34.88) | (22.71) | (84.53) |
| 10.99% | 50.27% | (116.28%) | (40.00%) | 45.50% | 46.62% | (207.67%) | (90.16%) | (26.20%) | (45.40%) | |
| 3.58% | 10.22% | (13.22%) | (8.47%) | 11.07% | 8.63% | (37.71%) | (32.43%) | (14.21%) | (27.25%) | |
ROIC |
3.11% | 17.30% | (20.17%) | (12.02%) | 20.47% | 20.93% | (90.31%) | (120.99%) | (28.50%) | (70.63%) |
Return on Tangible Assets |
6.14% | 25.97% | (46.80%) | (24.42%) | 25.86% | 20.11% | (106.18%) | (71.34%) | (18.68%) | (36.40%) |
Average Days of Receivables |
40.20 | 33.95 | 33.93 | 46.30 | 48.75 | 62.50 | 28.30 | 21.32 | 32.63 | 14.69 |
Research and Development Expense of Revenue |
6.59% | 7.33% | 10.29% | 8.14% | 7.58% | 9.17% | 14.95% | 14.49% | 13.92% | 14.41% |
Selling, General and Administrative Expense of Revenue |
16.76% | 13.79% | 20.20% | 20.32% | 13.22% | 17.13% | 28.32% | 22.94% | 23.14% | 27.39% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.93% | 1.38% | 2.07% | 1.67% | 0.54% | 1.14% | 1.93% | 1.44% | 1.47% | 1.92% |
Graham Net Nets |
(0.06) | (0.04) | (0.49) | (0.20) | (0.05) | (0.06) | (0.28) | (0.02) | 0.10 | 0.06 |
Graham Number |
0.29 | 0.59 | 0.00 | 0.00 | 0.45 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
1.21% | 2.67% | (13.88%) | (4.69%) | 1.25% | 2.89% | (30.39%) | (8.41%) | (4.73%) | (5.39%) |
Free Cash Flow Yield |
(9.52%) | (1.70%) | (10.28%) | (8.06%) | 0.23% | (9.06%) | (34.31%) | (6.07%) | (6.33%) | (1.82%) |
Revenue per Share |
0.88 | 0.84 | 0.75 | 0.76 | 0.65 | 0.45 | 0.34 | 0.42 | 0.40 | 0.35 |
Operating CF per Share |
(0.12) | 0.03 | (0.04) | (0.03) | 0.05 | (0.05) | (0.08) | (0.04) | (0.03) | (0.01) |
Capex per Share |
(0.03) | (0.07) | (0.02) | (0.06) | (0.04) | (0.02) | (0.02) | 0.00 | 0.00 | (0.01) |
Free Cash Flow per Share |
(0.15) | (0.04) | (0.06) | (0.09) | 0.01 | (0.08) | (0.10) | (0.04) | (0.03) | (0.01) |
Cash per Share |
0.02 | 0.02 | 0.03 | 0.04 | 0.01 | 0.03 | 0.03 | 0.04 | 0.06 | 0.06 |
Shareholders Equity per Share |
0.25 | 0.24 | 0.04 | 0.12 | 0.17 | 0.07 | 0.04 | 0.04 | 0.10 | 0.09 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.25 | 0.24 | 0.04 | 0.12 | 0.17 | 0.07 | 0.04 | 0.04 | 0.10 | 0.09 |
Free Cash Flow |
(10.71) | (2.59) | (3.06) | (4.47) | 0.45 | (2.94) | (3.52) | (1.50) | (1.03) | (0.41) |
Working Capital |
14.85 | 3.58 | 0.71 | 2.79 | 4.26 | 2.05 | 0.58 | 1.05 | 2.60 | 2.13 |
Capital Expenditures |
(2.14) | (4.56) | (1.05) | (2.82) | (1.87) | (0.88) | (0.74) | (0.16) | (0.07) | (0.16) |
Net Current Asset Value |
(3.64) | (5.71) | (14.68) | (11.28) | (9.33) | (1.97) | (2.88) | (0.50) | 1.59 | 1.38 |
EV/EBIT |
80.49 | 31.55 | 0.00 | 0.00 | 77.94 | 22.99 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.09 | 0.03 | 0.08 | 0.06 | 0.05 | 0.06 | 0.01 | 0.01 | 0.02 |
Price to Operating Income |
71.60 | 29.64 | 0.00 | 0.00 | 77.41 | 21.84 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.06 | 0.07 | 0.09 | 0.07 | 0.29 | 0.22 | 0.15 | 0.17 | 0.21 | 0.44 |
Cash ROIC |
(31.33%) | (12.11%) | (21.18%) | (27.75%) | 4.90% | (46.30%) | (81.33%) | (40.21%) | (18.42%) | (8.68%) |
Accounts Receivable Turnover |
10.60 | 12.56 | 9.10 | 8.61 | 8.58 | 8.78 | 13.91 | 14.60 | 16.10 | 22.92 |
Accounts Payable Turnover |
6.97 | 4.71 | 4.67 | 5.83 | 7.30 | 5.75 | 5.90 | 8.24 | 10.10 | 12.82 |
Inventory Turnover |
2.37 | 2.39 | 3.12 | 3.88 | 3.98 | 3.23 | 4.13 | 6.01 | 7.99 | 10.52 |
Average Days of Payables |
32.52 | 91.79 | 77.53 | 80.21 | 62.62 | 69.70 | 64.49 | 53.83 | 43.95 | 32.37 |
Days of Inventory on Hand |
146.88 | 204.58 | 124.23 | 111.41 | 107.03 | 142.29 | 94.23 | 75.06 | 58.64 | 37.36 |
Average Receivables |
5.85 | 4.17 | 4.10 | 4.34 | 3.43 | 1.95 | 0.90 | 0.97 | 0.77 | 0.47 |
Average Payables |
6.60 | 7.68 | 6.31 | 4.96 | 2.85 | 1.94 | 1.68 | 1.32 | 0.85 | 0.59 |
Average Inventory |
19.39 | 15.15 | 9.44 | 7.47 | 5.22 | 3.45 | 2.40 | 1.81 | 1.08 | 0.72 |
Average Assets |
50.03 | 41.44 | 33.22 | 30.98 | 20.97 | 11.46 | 7.97 | 6.42 | 5.55 | 4.71 |
Average Common Equity |
16.29 | 8.42 | 3.78 | 6.56 | 5.10 | 2.12 | 1.45 | 2.31 | 3.01 | 2.83 |
Columns are period end dates